标题
Genetic predisposition to prostate cancer: an update
作者
关键词
-
出版物
Familial Cancer
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-24
DOI
10.1007/s10689-021-00227-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- BARCODE 1: A pilot study investigating the use of genetic profiling to identify men in the general population with the highest risk of prostate cancer to invite for targeted screening.
- (2020) Ros A. Eeles et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
- (2020) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) C. Parker et al. ANNALS OF ONCOLOGY
- Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
- (2020) Veda N. Giri et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival outcomes in men with a positive family history of prostate cancer: a registry based study
- (2020) Mann Ang et al. BMC CANCER
- PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer
- (2019) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
- (2019) Piper Nicolosi et al. JAMA Oncology
- Bringing prostate cancer germline genetics into clinical practice
- (2019) Sanjay Das et al. JOURNAL OF UROLOGY
- Genetic testing for hereditary prostate cancer among men in Israel
- (2019) S. Golan et al. EUROPEAN UROLOGY SUPPLEMENTS
- Prostate Cancer Incidence and Mortality in Relationship to Family History of Prostate Cancer; Findings from The PLCO Trial.
- (2019) Omar Abdel-Rahman Clinical Genitourinary Cancer
- Platinum-based chemotherapy in metastatic prostate cancer with alterations in DNA damage repair genes.
- (2019) Jose Mauricio Mota et al. JOURNAL OF CLINICAL ONCOLOGY
- Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
- (2019) Tobias Nordström et al. BMJ Open
- Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study
- (2019) Tommy Nyberg et al. EUROPEAN UROLOGY
- Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
- (2019) Tom Callender et al. PLOS MEDICINE
- A Review of Prostate Cancer Genome-Wide Association Studies (GWAS)
- (2018) Sarah Benafif et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017
- (2018) Veda N. Giri et al. JOURNAL OF CLINICAL ONCOLOGY
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
- (2018) Fredrick R. Schumacher et al. NATURE GENETICS
- Malignant Abnormalities in Male BRCA Mutation Carriers
- (2018) Roy Mano et al. JAMA Oncology
- The GENTleMEN study: Genetic testing for men with metastatic prostate cancer in Washington state and beyond.
- (2018) Heather H. Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
- (2018) Zafeiris Zafeiriou et al. EUROPEAN UROLOGY
- Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer
- (2018) H. Ballentine Carter et al. EUROPEAN UROLOGY
- Homeobox B13 G84E Mutation and Prostate Cancer Risk
- (2018) Tommy Nyberg et al. EUROPEAN UROLOGY
- Inherited NBN Mutations and Prostate Cancer Risk and Survival
- (2018) Bogna Rusak et al. Cancer Research and Treatment
- Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores
- (2017) Julie Lecarpentier et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
- (2017) Hashim U Ahmed et al. LANCET
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer
- (2016) Elena Castro et al. ONCOLOGIST
- A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)
- (2015) Marco Randazzo et al. BJU INTERNATIONAL
- Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
- (2015) Elena Castro et al. EUROPEAN UROLOGY
- Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
- (2015) Nora Pashayan et al. GENETICS IN MEDICINE
- Impact of Family History on Prostate Cancer Mortality in White Men Undergoing Prostate Specific Antigen Based Screening
- (2015) Michael A. Liss et al. JOURNAL OF UROLOGY
- Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
- (2015) Henrik Grönberg et al. LANCET ONCOLOGY
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
- (2014) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer
- (2014) J. B. Hjelmborg et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
- (2013) V. H. Laitinen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
- (2013) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- Does Positive Family History of Prostate Cancer Increase the Risk of Prostate Cancer on Initial Prostate Biopsy?
- (2013) Ahmed Elshafei et al. UROLOGY
- An inherited NBN mutation is associated with poor prognosis prostate cancer
- (2012) C Cybulski et al. BRITISH JOURNAL OF CANCER
- Potential Impact of Adding Genetic Markers to Clinical Parameters in Predicting Prostate Biopsy Outcomes in Men Following an Initial Negative Biopsy: Findings from the REDUCE Trial
- (2012) A. Karim Kader et al. EUROPEAN UROLOGY
- A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
- (2012) Robert Karlsson et al. EUROPEAN UROLOGY
- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer
- (2011) A. Brandt et al. ANNALS OF ONCOLOGY
- Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
- (2010) Anita V. Mitra et al. BJU INTERNATIONAL
- Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
- (2010) D. J. Gallagher et al. CLINICAL CANCER RESEARCH
- 960 THE INFLUENCE OF A POSITIVE FAMILY HISTORY ON PROSTATE CANCER INCIDENCE AND DUTASTERIDE EFFICACY IN THE REDUCE STUDY
- (2010) T.L.J. Tammela et al. EUROPEAN UROLOGY SUPPLEMENTS
- Risk Stratification and Validation of Prostate Specific Antigen Density as Independent Predictor of Progression in Men With Low Risk Prostate Cancer During Active Surveillance
- (2010) Ignacio F. San Francisco et al. JOURNAL OF UROLOGY
- Effect of Dutasteride on the Risk of Prostate Cancer
- (2010) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Associations of High-Grade Prostate Cancer with BRCA1 and BRCA2 Founder Mutations
- (2009) I. Agalliu et al. CLINICAL CANCER RESEARCH
- Finding the missing heritability of complex diseases
- (2009) Teri A. Manolio et al. NATURE
- Estimation of absolute risk for prostate cancer using genetic markers and family history
- (2009) Jianfeng Xu et al. PROSTATE
- Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium
- (2008) Z. Kote-Jarai et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Multiple newly identified loci associated with prostate cancer susceptibility
- (2008) Rosalind A Eeles et al. NATURE GENETICS
- Cumulative Association of Five Genetic Variants with Prostate Cancer
- (2008) S. Lilly Zheng et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started